Sorry, you need to enable JavaScript to visit this website.
DeliverinG THE LATEST
GREENSTONE News

Get up-to-date product and event news, including information on our generic products.

GREENSTONE LLC INTRODUCES SILDENAFIL CITRATE TABLETS Authorized Generic of VIAGRA® (sildenafil citrate) Tablets

PEAPACK, NJ, December 2017—Greenstone LLC, a US-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Sildenafil Citrate tablets to its ever-expanding generic pharmaceutical product line. The product is offered and available in presentations of 25 mg, 50 mg, and 100 mg tablets.
 
Read more »

URGENT: REVISED DRUG RECALL diphenoxylate hydrochloride and atropine sulfate tablets, USP – CV

 URGENT: REVISED DRUG RECALL
diphenoxylate hydrochloride and atropine sulfate tablets, USP – CV

NDC                    Lot Number            Expiration Date             Strength                      Configuration/Count
59762‐1061‐1     R83962                   2021 OCT 31               2.5 mg/0.025 mg         Bottle containing 100 tablets
59762‐1061‐1     R93347                   2021 OCT 31               2.5 mg/0.025 mg         Bottle containing 100 tablets
Read more »

GREENSTONE ISSUES VOLUNTARY NATIONWIDE RECALL OF DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE TABLETS, USP DUE TO POSSIBLE SUB POTENT AND SUPER POTENT TABLETS

Greenstone Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP Due to Possible Sub Potent and Super Potent Tablets
 
 
Media Contact: 610-329-1340
 
 
For Immediate Release – PEAPACK, NJ, November 16, 2017 - Greenstone LLC, a wholly owned subsidiary of Pfizer Inc., is  voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level. Greenstone initiated this recall because product from these lots has the potential to be super potent or sub potent.Read more »

Important Product Expiration Date Information Regarding Medroxyprogesterone Acetate Injectable Suspension, USP

Medroxyprogesterone Acetate Injectable Suspension, USP, (pre-filled syringe) distributed by Greenstone LLC may contain two different product expiration dates printed on its individual components. Please note that the date printed on the outer carton of the combination pack should be considered as the overall expiration date of the combination product.

There are no known safety or labeling concerns which have been associated with this situation.

Read more »

Product Recall

Pfizer initiates voluntary recall of two lots of Pfizer's EFFEXOR XR® 150 mg extended-release capsules and one lot of Greenstone's VENLAFAXINE HCL 150 mg extended-release capsules. Click here for more information.

Read more »